Reduced Intensity Transplantation for Primary Immunodeficiency Disorders
Author:
Open Access
- 17 June 2011
- journal article
- research article
- Published by MDPI AG in Pediatric Reports
- Vol. 3 (12) , 28-31
Abstract
Studies so far indicate that reduced intensity transplantation (RIT) may have an important role in treating patients with primary immunodeficiency disease (PID). Unlike more standard approaches, such regimens can be used without severe toxicity in patients with severe pulmonary or hepatic disease. RIT also offers the advantage that long-term sequelae such as infertility or growth retardation may be avoided or reduced. RIT appears to be most appropriate for those patients with significant co-morbidities (eg T cell deficiencies) and those undergoing unrelated donor haematopoietic cell transplantation. More studies are required using pharmacokinetic monitoring (eg busulphan, treosulfan and alemtuzumab) and varying stem cell sources to optimise graft vs marrow reactions and minimise graft vs host disease. In certain PID patients RIT will be the “first step” towards establishing donor cell engraftment; second infusions of donor stem cells, donor lymphocyte infusions, or a second myeloablative HCT, which appears to be well tolerated, may be required in some patients with low level donor chimerism or graft rejection.Keywords
This publication has 18 references indexed in Scilit:
- Treosulfan‐containing regimens achieve high rates of engraftment associated with low transplant morbidity and mortality in children with non‐malignant disease and significant co‐morbiditiesBritish Journal of Haematology, 2008
- Increasing mixed chimerism and the risk of graft loss in children undergoing allogeneic hematopoietic stem cell transplantation for non-malignant disordersBone Marrow Transplantation, 2008
- Using allogeneic stem cell/T-cell grafts to cure hematologic malignanciesExpert Opinion on Biological Therapy, 2008
- Reduced intensity conditioning and allogeneic stem cell transplantation in childhood malignant and nonmalignant diseasesBone Marrow Transplantation, 2007
- Intensive postgrafting immune suppression combined with nonmyeloablative conditioning for transplantation of HLA-identical hematopoietic cell grafts: results of a pilot study for treatment of primary immunodeficiency disordersBone Marrow Transplantation, 2007
- Stem cell transplantation with reduced-intensity conditioning regimens: a review of ten years experience with new transplant concepts and new therapeutic agentsLeukemia, 2006
- Successful Low Toxicity Hematopoietic Stem Cell Transplantation for High-Risk Adult Chronic Granulomatous Disease PatientsTransplantation, 2005
- Higher Mortality After Allogeneic Peripheral-Blood Transplantation Compared With Bone Marrow in Children and Adolescents: The Histocompatibility and Alternate Stem Cell Source Working Committee of the International Bone Marrow Transplant RegistryJournal of Clinical Oncology, 2004
- Lineage-specific chimaerism after stem cell transplantation in children following reduced intensity conditioning: potential predictive value of NK cell chimaerism for late graft rejectionLeukemia, 2003
- Harnessing graft-versus-malignancy: non-myeloablative preparative regimens for allogeneic haematopoietic transplantation, an evolving strategy for adoptive immunotherapyBritish Journal of Haematology, 2000